(Q40100573)

17 September 2017

1 reference

title

Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure (English)

1 reference

17 September 2017

0 references

congestive heart failure

1 reference

1

W. S. Colucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6166194

19 August 2023

author name string

G. H. Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6166194

19 August 2023

R. W. Alexander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6166194

19 August 2023

E. Braunwald

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6166194

19 August 2023

language of work or name

English

0 references

publication date

1 July 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0002934381902631?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

https://api.elsevier.com/content/article/PII:0002934381902631?httpAccept=text/plain

19 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

American Journal of Medicine

19 August 2023

published in

1 reference

17 September 2017

volume

71

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

89-99

1 reference

Vasodilator therapy--a physiologic approach to the treatment of heart failure

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Vasodilator therapy of cardiac failure: (first of two parts)

19 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Vasodilator therapy of cardiac failure (second of two parts).

19 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

19 August 2023

Symposium perspective

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Oral vasodilator therapy for chronic heart failure: A plea for caution

19 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

How much can we expect from vasodilator therapy in congestive heart failure?

19 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure

19 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Plasma norepinephrine in congestive heart failure

19 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE

19 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

19 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Alterations in the baroreceptor reflex in conscious dogs with heart failure

19 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Impaired atrial receptor responses in dogs with heart failure due to tricuspid insufficiency and pulmonary artery stenosis

19 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Phentolamine for vasodilator treatment of severe heart-failure

19 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

19 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade

19 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

19 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

19 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

19 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Arterial Sodium Content in Experimental Congestive Heart Failure

19 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

The contribution of local factors to the elevated venous tone of congestive heart failure

19 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema

19 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

The role of the sodium pump in the control of vascular tone in the rat

19 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Vasodilation for Vasospastic Hypertension

19 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat

19 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

19 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Altered renin release and propranolol potentiation of vasodilatory drug hypotension

19 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart Failure

19 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Presynaptic regulation of catecholamine release

19 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

A functional basis for classification of α-adrenergic receptors

19 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Pharmacological classification of adrenergic α receptors in the guinea pig

19 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Alpha-adrenergic receptor subtypes: Quantitative assessment by ligand binding

19 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Characterization of postsynaptic alpha-adrenergic receptors by [3H]-dihydroergocryptine binding in muscular arteries from the rat mesentery

19 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

The Role of α- and β-Presynaptic Receptors in the Regulation of Noradrenaline Release Elicited by Nerve Stimulation

19 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Inhibitory effect of propranolol on the vasoconstrictor response to sympathetic nerve stimulation

19 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Dual Adrenoceptor-mediated Control of Noradrenaline Secretion from Human Vasoconstrictor Nerves: Facilitation by β-receptors and Inhibition by α-receptors

19 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.

19 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Evidence for a renal alpha-adrenergic receptor inhibiting renin release

19 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension

19 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

19 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

19 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Hormonal regulation of peptide receptors and target cell responses

19 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Direct Binding Studies of Adrenergic Receptors: Biochemical, Physiologic, and Clinical Implications

19 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Regulation of the postsynaptic alpha-adrenergic receptor in rat mesenteric artery. Effects of chemical sympathectomy and epinephrine treatment

19 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Isoproterenol vasomotor reversal by sympathomimetic amines

19 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Evidence for uncoupling of the beta receptor-adenylate cyclase complex

19 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

19 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

19 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure

19 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure

19 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema

19 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure

19 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Effect of prazosin vs placebo on chronic left ventricular heart failure

19 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Long-term therapy of heart failure with prazosin: a randomized double blind trial

19 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

The cause, relief and prevention of headaches arising from contact with dynamite

19 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

A study of cross-tolerance to circulatory effects of organic nitrates

19 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate

19 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Evaluation of Nitroglycerin in Angina in Patients on Isosorbide Dinitrate

19 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use

19 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Mechanism of tolerance development to organic nitrates

19 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Hemodynamic effects of intravenous sodium nitroprusside in the conscious dog

19 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Renin Release during Acute Reduction of Arterial Pressure in Normotensive Subjects and Patients with Renovascular Hypertension*

19 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure

19 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure

19 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Effect of hydralazine on renal failure in patients with congestive heart failure

19 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Oral hydralazine therapy for chronic refractory heart failure

19 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Alterations in the baroreceptor reflex in conscious dogs with heart failure

19 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Vasodilator therapy for chronic left ventricular failure

19 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes

19 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

19 August 2023

Drug therapy. Prazosin

85

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure

19 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure

19 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure

19 August 2023

90

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure

19 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs.

19 August 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

19 August 2023

93

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat

19 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

19 August 2023

95

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart

19 August 2023

96

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle

19 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure

19 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-9343(81)90263-1

19 August 2023

Identifiers

1 reference

17 September 2017

1 reference